思利舒治疗精神分裂症疗效观察
Zhejiang Journal of Integrated Traditional Chinese and Western Medicine（2007）
Abstract
思利舒(利培酮)是新型抗精神病药,是具有平衡机制的5-羟色胺/多巴胺受体拮抗剂.与经典的抗精神病药相比,引起锥体外系及嗜睡等中枢神经系统不良反应少[1].笔者采用开放性研究,对国产思利舒的临床疗效与安全性进行观察和评价,现将结果报道如下.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined